4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-24-020664
Chief Financial Officer gave up 196 shares (to pay taxes)
- Chief Financial Officer acquired 834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2024-06-16 | Option exercise | +834 | 6,207 | D: show line 1 in the form | ||
| Foster Jonathan P. Chief Financial Officer | 2024-06-16 | Shares withheld for taxes | −196 | $4.14 | $811 | 6,011 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2024-06-16 | Option exercise · Restricted Stock Units | −834 | 71,878 | D: show line 3 in the form |
Loading xslF345X05/rdgdoc.xml…